| |
| Device | GORE® CARDIOFORM Septal Occluder; GORE® CARDIOFORM ASD Occluder |
| Generic Name | Transcatheter septal occluder |
| Applicant | W. L. Gore & Associates, Inc. 32360 N. N. Valley Pkwy. Phonix, AZ 85085 |
| PMA Number | P050006 |
| Supplement Number | S119 |
| Date Received | 07/07/2026 |
| Decision Date | 08/03/2026 |
| Product Code |
MLV |
| Advisory Committee |
Cardiovascular |
| Supplement Type | Special (Immediate Track) |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for modifications to the Instructions for Use (IFU) for the GORE® CARDIOFORM Septal Occluder and GORE® CARDIOFORM ASD Occluder to add instructions of optional delivery system manipulation techniques in the event of a delayed lock has occurred at device deployment |